Introduction
The mineralocorticoid receptor (MR) exhibits a complex pattern of responsiveness to mineralocorticoids and glucocorticoids. Indeed MR has a higher affinity for glucocorticoids than mineralocorticoids and is more sensitive to glucocorticoids than the glucocorticoid receptor (GR) (1, 2) . In epithelial tissues such as the tubules of the kidney and the distal colon, specificity of MR signaling in response to mineralocorticoids is maintained by the expression of 11 -hydroxysteroid dehydrogenase (11 HSD2), which converts cortisol or corticosterone to inactive keto-metabolites (3) . In tissues where 11 HSD2 is not expressed, such as within the brain and vascular system, basal glucocorticoid levels are sufficient to transmit transcriptional responses through MR. By contrast, signaling through GR reflects the diurnal variation of glucocorticoid levels and acute responses to stimulation of the hypothalamic-pituitary axis. Where the potential for signaling through both MR and GR exists, the activation of each receptor communicates distinct physiological outcomes (4, 5) . Glucocorticoid signaling in these tissues involves both overlapping targeting of MR and GR in the nucleus and heteromeric interactions between the two receptors (6-10).
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In the present study, we have performed a detailed examination of the movement of MR between cytoplasm and nucleus. By contrast to other nuclear receptors, we report transfer of MR to nucleus is essentially unidirectional. Further, the localization of MR to the nucleus in the absence and presence of hormone was dependent upon the complex interplay of three NLSs of different composition located respectively in the N-terminus, DBD and LBD of the receptor.
The N-terminal MR NLS, which was found to be primarily responsible for the nuclear localization of the naive receptor, is of a novel type consisting of a serine/theronine rich motif that we show has the potential to be regulated by specific phosphorylation.
by guest on November 17, 2017 http://www.jbc.org/ Downloaded from 7 residues 561-570 and residue 601S/D in the context of GFP-MR the QuikChange Mutagenesis kit (Stratagene) was used.
The GST coding sequence was PCR amplified and then subcloned into pEGFP-C1. The derivative plasmids of pGSTGFP that express MR or GR peptides C-terminal to the GST-GFP moiety (as indicated in the figures) were generated by PCR amplification of the appropriate sequence. In the case of plasmids GSTGFPNL0 592/4/5A , GSTGFPNL0 592/4/5D , GSTGFPNL0 597/8/601A GSTGFPNL0 597/8/601D and the derivatives constructed with individual amino acid substitutions at the same positions, the appropriate mutations were introduced using PCR primers. Mutant expression constructs MR-DBD, MR-DBD WN , MR-DBD NW and MR-DBD NN were sub-cloned by first generating the specified mutation in pTLBuMR using the Stratagene QuikChange mutagenesis kit, followed by PCR amplification of the mutated sequence and subsequent insertion into pGSTGFP. The GGM NL1-E959Q plasmid was constructed by replacing the fragment encoding amino acids 923-981of MR in the GGM NL1-construct with the same fragment containing the point mutation E959Q previously described (17) .
Expression of MR constructs in SF9 cells was performed using the pIZ/V5-His (Invitrogen) expression vector. The pGSTGFPMR constructs for expression in insect cells were prepared by cloning the relevant fragments from the mammalian expression vectors pGFPMR, pGFPMR 590-602 , GSTGFPNL0 592/4/5A , GSTGFPNL0 592/4/5D , GSTGFPNL0 597/8/601A , GSTGFPNL1, GSTGFPNL1-and GSTGFPNL0 597/8/601D , described above into pIZ/V5-His. All expression vector inserts were verified by automated sequencing. The expression levels of all constructs were verified by western analysis following transient transfection in Cos7 cells as described previously (20) . 
Quantification of Subcellular Distribution
For analysis of subcellular distribution in Cos7 and Hela cells, following transfection the cells were culture in complete serum overnight and then seeded onto 22 mm square coverslips.
Cells were allowed to attach for 8 h. To restrict the synthesis of new receptor during the course of the experiment cells were then synchronized in G 0 by serum withdrawal for 16 h. Cells were treated with 1 µM cortisol, aldosterone, or spironolactone as indicated with cycloheximide included in some experiments. To initiate steroid withdrawal, cells were rinsed five times, 5 min at 37 C, in 1 x PBS containing 5% (w/v) bovine serum albumin and then twice in serum-free media. The cells were rinsed a final time in serum-free media and incubated at 37 C for the indicated withdrawal period.
For direct visualization of GFP fluorescence, cells were fixed with 3% paraformaldehyde for 30 min at 4°C followed by incubation with PBS containing 0.2 M glycine for 10 min at 20°C.
Coverslips were mounted onto microscope slides, overlaid with 50% glycerol in PBS and sealed with nail polish. Cells were scored into five categories from exclusively nuclear (N) to exclusively cytoplasmic (C) as previously described (22) . Quantification was performed using double-blind encryption with individual data points derived from a minimum of 1000 cells quantified over three independent experiments performed in duplicate.
For indirect immunofluorescence, following fixation in 3% paraformaldehyde and incubation with 0.2 mM glycine in PBS, cells were permeabilised by incubation with Triton X-the coverslips were washed three times in PBS and then incubated at 20°C for 45 min with rhodamine red-X conjugated secondary antibody (Jackson Immunoresearch Laboratories) diluted in PBS [1/150 (v/v) ]. Cells were mounted onto glass coverslips as described for direct analysis of subcellular distribution. Following double-blind encryption subcellular distribution was quantified as described previously (20, 22) .
Fluorescence Recovery After Photobleaching (FRAP) Assays.
Cos7 and HeLa cells were seeded into Bioptechs delta T4 culture dishes. Transient transfection with the expression plasmids indicated was carried out using 500ng plasmid DNA and 8ul LipofectAMINE per dish, following the manufacturer's protocol. After overnight incubation in OptiMEM serum-reduced medium, transfection was stopped by replacing media with phenol-red-free complete media containing 10% charcoal-stripped FBS. Cells were grown in the complete media for 8h, then withdrawn from serum for 16h prior to FRAP or FLIP assays.
Results

Rapid nuclear import of MR in response to ligand is mediated through a bipartite NLS
In this study we sought to examine the nuclear cytoplasmic trafficking of MR over periods of up to 24h. Fig   1A) ., indicating that minimal new synthesis of receptor occurred during this time. Aldosterone treatment induced a reduction in MR levels over the 24 h period, an indication of a destabilization in response to steroid that is common to steroid receptors (42) . This reduction in MR levels also was unaffected by cycloheximide treatment.
To quantify MR localization through direct and indirect immunofluorescence, we employed a localization scoring protocol that we and others have described previously (20, 22, 43) . Using this approach, MR expressed in Cos7 cells was determined to be distributed by guest on November 17, 2017 http://www.jbc.org/ Downloaded from 13 evenly between nucleus and cytoplasm in over 80% of the cells (Fig. 1B) . This was consistent with results of earlier studies examining the localization of naïve MR (24) (25) (26) (27) .
Previous experiments with GR have shown that over expression of the receptor in Cos7 cells results in an artificial shift of the receptor towards the nucleus (44, 45) . However this appeared unlikely to explain the partial nuclear accumulation of MR here, as our MR constructs were expressed at levels 4-6 fold lower than similarly tagged GRs (data not shown) that were localized almost exclusively to the cytoplasm in parallel experiments (Fig 1B) . Upon steroid treatment, both MR and GR transferred rapidly and completely to the nucleus (Fig 1B) .
Nuclear receptors characteristically possess a major NLS, termed NL1, which is comprised of basic amino acids at the C-terminal region of the receptor DNA binding domain.
For rat GR, amino acids 510 to 517 comprise the core of the NLS and are required for NL1 activity (Fig 1C) . Alignment of MR with GR revealed a potentially disruptive two amino acid (LG) insertion within the analogous basic amino acid cluster of MR. However, a second basic motif between amino acids 488-493 that may supplement the NLS activity of the core NL1 motif of GR (46) , was precisely represented in MR.
Asparagine substitutions at lysine residues in the second basic cluster of GR previouslyhave been shown to completely abrogate GR NL1 activity (GR NL1 -) and to restrict over expressed and antagonist treated GR to the cytoplasm (22) . The analogous substitutions in MR (MR NL1 -, Fig 1C) had only a modest effect on the localization of naïve MR, with the receptor remaining mostly nuclear or evenly distributed between nucleus and cytoplasm in approximately 65% of the cells (Fig 1D) . Upon steroid treatment, nuclear transfer of MR NL1 -was reduced relative to the nuclear localization of WT MR with the receptor becoming at least mostly nuclear in only 70% of the cells. However, this localization of MR NL1 -to the nucleus in 14 response to aldosterone still exceeded the nuclear localization of GR NL1 -following cortisol treatment.
For GR, its transcriptional activation potential has been shown to be directly proportional to the extent of its transfer to the nucleus following steroid treatment. To determine whether the
NL1
-substitution that impeded MR nuclear localization also affected the transcriptional regulatory potential of MR, we compared the ability of WT and NL1 -MR and GR to induce transcription through the steroid response elements of mouse mammary tumor virus ( Fig 1E) . As observed previously, the NL1 -substitution in GR reduced transcription from the MMTV promoter (22) . By contrast MR NL1 -induced transcription to the same extent as WT MR,
suggesting that the NL1 -substitution in MR did not affect localization sufficiently to affect the receptors transactivation potential.
While our data implicated MR lysines 677, 678 and 681 as contributing to the MR NL1 activity, the reduced consequence of substitution at these positions compared to GR suggested that the MR NL1 signal might be more complex than the GR signal. To evaluate the relative importance of the two basic motifs in MR for NL1-mediated nuclear import, we examined the subcellular distribution of a series of MR peptides encompassing the MR DBD to the end of the NL1 region expressed as fusion proteins with GFP coupled to glutathione-S-transferase (GSTGFP; Fig 1F) .
Active transport through the nuclear pore is required for proteins above 70 kDa in size.
Smaller proteins can also gain access to the nucleus through passive diffusion. Thus at 50kDa, GSTGFP alone is small enough to have retained the ability to access the nucleus through passive diffusion (47) and thus was observed in our experiments to be equally distributed between nucleus and cytoplasm of most cells (Fig 1F) .
Addition of the MR DBD peptides to GSTGFP increased the size of the fusion proteins expressed to 70 kDa, a size at which passive diffusion would be expected to be restricted and the proteins localized predominantly to the cytoplasm in the absence of an NLS. The strong NL1 activity within the WT MR peptide directed the GFPGSTMR DBD peptide almost completely to the nucleus (Fig 1F) . Analysis of the localization of several GR/MR chimeras substantiated this hypothesis and pointed to the presence of a novel NLS in the N-terminus of MR (Fig 2A) . An MR/GR chimera consisting of the N-terminus and DBD of GR fused to the LBD of MR (GGM) localized to the cytoplasm in the absence of steroid in a manner comparable to unliganded GR. Similarly, a GMM construct comprised of the N-terminus of GR and the DBD and LBD of MR also was cytoplasmic. By contrast, the reverse MGG construct displayed a partially nuclear localization that was similar to that of MR. All constructs were steroid responsive and moved completely to the nucleus upon steroid treatment (data not shown).
Expression of the 602 amino acids comprising the N-terminus of MR fused to GFP confirmed the presence of a nuclear localization activity which mimicked that observed for naïve WT MR (Fig 2B) . However, examination of the sequence of the N-terminus of MR failed to reveal any strong similarities to classical basic nuclear localization signals. Thus to delimit the location of the putative NLS within this region of MR, we initiated a comparison of the localization of the N and C-terminal deletion constructs of the MR N-terminus fused to GFP ( Fig   2B) . Intriguingly, the first construct prepared, lacking the first 150 amino acids of the MR Nterminus (MR 150-602 ) was strongly shifted towards the nucleus, suggesting that this region of MR may contain an activity that helps to retain the protein in the cytoplasm. By contrast, deletion of 50 amino acids from the C-terminus of MR 1-602 resulted in a GSTMR fusion protein (MR that was almost completely cytoplasmic.
Close examination of the amino acids in the 550-602 region of MR indicated a match in the spacing between three basic residues in this region and the NLS of Borna disease virus 17 (BDV) protein p10 (48) . However, a substitution within MR (R561N/R562N) analogous to that which abrogated the activity of the p10 NLS failed to compromise the nuclear localization of GFPMR (Fig 2B) .
Expression of MR amino acids 550-602 in fusion with GFPGST confirmed that this region of MR contained NLS activity, which we have termed NL0 (Fig 2C) . Further, this nuclear localization activity was compromised upon deletion of just 7 amino acids from the Cterminus of the MR peptide (MR 550-595 ), indicating that amino acids 595-602 were important for NLS function.
The striking feature of the 550-602 region of MR is a cluster of 5 serines and 1 threonine residue between amino acids 590-602 (see Fig 3) . This S/T-rich region was determined to be required for the nuclear localization of naïve MR, as deletion of amino acids 590-602 from full length MR strongly reduced nuclear occupancy of the receptor in the absence of steroid (Fig 2D) .
MR 590-602 still transferred completely to the nucleus completely in response to aldosterone, indicating that NL0 was not required for nuclear localization of the liganded receptor.
To assess in detail the importance of the S/T cluster to NL0 and whether NL0 might be susceptible to modulation through modification of one or more of these residues, we compared the subcellular localization of GSTGFPMR 550-602 fusion proteins with alanine and aspartic acid substitutions (Fig 3) . Localization of GSTGFPMR 550-602 was unaffected by S/A substitution of amino acids 592,594,595 (Fig 3A) . By contrast, S/D substitutions at the same positions significantly enhanced nuclear localization of the fusion protein. Conversely S/A substitutions at S597/598/601 yielded a fusion protein (GSTGFP NL0597/598/601D ) that was significantly shifted to the nucleus. Strikingly, mimicking phosphorylation with S/D substitutions at the same positions eliminated NL0 activity, resulting in a fusion protein with localization similar to that of GSTGFP.
Next, we refined our analysis to consider the effects of single amino acid substitution on the localization of GSTGFPMR 550-602 (Fig 3B) . Individual substitution of D for S or T at amino acids 592, 594 and 595, only had modest if any effect on the localization of GSTGFPMR 550-602 ,
suggesting that the enhancement of NL0 activity observed in Fig 3A resulted from the accumulation of negative charge at all three positions.
Individual S/D substitutions at amino acids 597 and 598 also had little effect on the NL0 activity. However, S/D substitution at amino acid 601 was sufficient to abrogate nuclear localization of GSTGFPMR 550-602. These results suggested that serine 601 of MR might be crucial for NL0 activity and suggest that its modification may provide a means to localize MR to the cytoplasm. By contrast, it appears that potentiation of NL0 activity would require the cumulative modification of at least serines 592, 594 and threonine 595.
To determine the potential for modification of serine 601 to modify the localization of full length MR, we assessed the affect of the S601D substitution on the localization of the full length MR expressed as a GFP fusion protein (Fig 3C) . WT GFPMR was distributed equally between nucleus and cytoplasm in at least 90% of the cells. By contrast, GFPMR S601D was shifted towards the cytoplasm to the same relative extent as we had observed earlier in Fig 2D for MR D590-602 . These data highlight that the S/T cluster between amino acids 590 and 602 of MR are integral to the MR NL0 nuclear localization signal and suggest that modification of serine 601 through phosphorylation may act to restrict naïve MR to the cytoplasm. However as before with MR 590-602 , the S601D substitution failed to interfere with the transfer of MR to the nucleus in response to aldosterone. Moreover, MR S601D stimulated reporter gene transcription from the MMTV promoter to the same extent as WT MR (Fig 3D) .
While naïve MR has been reported to be distributed throughout the cell in most cell types, the naïve receptor has been reported to be largely cytoplasmic when ectopically expressed in insect cells (49) (50) (51) (52) . As the activity of most nuclear localization signals is conserved between yeast and higher vertebrates (53) , these reports suggested that the MR NL0 motif might be specific to mammalian cells.
To determine the potential for NL0 to function in insect cells we expressed our series of GSTGFPNL0 constructs in SF9 cells (Fig 4) . 
MR exhibits a steroid-dependent NL2 activity
In addition to the NL1 NLS, GR, and ER have been shown to have a second NLS, termed NL2, which occurs within their LBDs. NL2 is a strictly steroid-dependent NLS that mediates slower and incomplete nuclear transfer into the nucleus (18) . NL2 mediated nuclear import of GR recently has been shown to be dependent upon importin 7 (54). NL2 is localized within the 20 LBD of GR/ER, but does not feature an obvious basic amino acid motif (18, 43) . The MR LBD, when expressed alone (MR 690C ), responded to aldosterone treatment by strongly increasing its localization to the nucleus (Fig 5A) , indicating that the MR LBD also contains an NL2 nuclear localization activity.
The Fig   5B) . This reduction in transcriptional activation potential was similar to the difference seen previously between GR and GR NL1 - (22) , suggesting a threshold relationship between nuclear localization and transcriptional activation by MR rather than a strictly linear correlation.
NL1 mediated nuclear import of WT MR and WT GGM occurred rapidly upon exposure to steroid, being largely complete with 10 min of treatment (data not shown), as is typical for nuclear import occurred more slowly (Fig 5C) , with localization of GGM NL1 -reaching steady state in just over an hour.
While the MR NL2 was similarly responsive to aldosterone, cortisol and the synthetic glucocorticoid dexamethasone (data not shown), the response appeared to be almost completely dependent on steroid agonist, as the mineralocorticoid antagonist spironolactone stimulated little if any transfer of GGM NL1 -to the nucleus (Fig 5D) . By contrast, spironolactone strongly stimulated the transfer of MR to the nucleus in these experiments. Spironolactone also effectively competed the transcriptional response of GGM NL1 -and MR to steroid agonist (data not shown).
The strict agonist dependency of the MR NL2 activity suggested the possibility that this activity reflected the cotransport of MR to the nucleus with transcriptional coactivators that interact with the steroid-dependent AF-2 transactivation function in the MR LBD. To assess this possibility, we tested the effect of a substitution in GGM NL1 -(GGM NL1 -E959Q ) that has recently been shown to abrogate AF-2 function without affecting steroid binding (56, 57) . Localization of GGM NL1 -E959Q exactly paralleled localization of GGM NL1 -, with aldosterone treatment inducing a similar accumulation of the two proteins in the nucleus (Fig 5E) . This supports NL2 being an inherent property of the MR LBD rather than a reflection of the cotransport of MR by coactivator factors.
Localization of the naïve receptors was also similar in this experiment, although in this series both GGM NL1 -and GGM NL1 -E959Q were somewhat shifted to the cytoplasm in the absence of steroid compared to the earlier experimental series shown in Fig 5C. The reason for this variation in initial receptor distribution remains to be clarified, but appear to correlate with variations in the serum employed to maintain the cells. 
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Transfer of MR between cytoplasm and nucleus is essentially unidirectional.
A complex aspect of steroid receptor action is the degree to which steroid hormone receptors exchange or shuttle between nucleus and cytoplasm. We recently have demonstrated that nuclear export of WT GR occurs only very slowly with a t 1/2 of several hours under normal cell culture conditions (58) . This slow rate of nuclear export was observed both for liganded GR and for receptor following the withdrawal of steroid treatment. Other nuclear receptors exhibit similar slow nuclear export under at least some conditions (55) . The slow export of GR from the nucleus appears to result from active retention of the receptor within the nucleus through a process that involves a signal that overlaps with NL1 1 . Thus the NL1 -substitution in GR results in a receptor that is lost from the nucleus upon the withdrawal of steroid treatment with a half time of approximately 1-2 h (22).
By contrast to GR, transfer of MR between cytoplasm and nucleus unexpectedly appeared to be essentially unidirectional in Cos7 cells (Fig 6) . In the first instance, treatment of cells with 10 M aldosterone, a concentration of steroid sufficient to saturate both MR and GR, induced the rapid and complete nuclear transfer of both receptors to the nucleus (Fig 6A) .
Steroid withdrawal was accomplished through extensive washing of the cells in the presence of BSA, which has steroid binding activity.
Upon steroid withdrawal GR returned to the cytoplasm over a 16 h period (Fig 6A) , in the same way GR has been observed previously to return to the cytoplasm in cells withdrawn from cortisol or the synthetic steroid dexamethasone (21, 22, 38) . By contrast we were unable to 23 detect redistribution of MR from the nucleus over the same period. This did not appear to be simply a result of more active nuclear retention coincident with the MR NL1. Substitution of lysines 677,678 and 681 in MR, which is the substitution directly analogous to the GR NL1 -substitution that dramatically accelerates GR nuclear export, had only a marginal effect in rescuing nuclear export of MR following steroid withdrawal (Fig 6B) . Compared to GR NL1 -where export to the cytoplasm is complete within 1-2 h (22), only approximately 20% of MR NL1 -redistributed from nuclear to N=C over 24 h following the withdrawal of aldosterone.
To study the movement of proteins between nucleus and cytoplasm in greater detail we In Cos7 cells expressing a synthetic GFP control protein in which nuclear import is directed by the SV40 NLS and nuclear export by the HIV Rev NES, re-equilibration of GFP fluorescence between nuclei of multinucleated cells following photobleaching of one nucleus approached completion within 30 min of FRAP (Fig 6C) . By contrast, no significant recovery of fluorescence was observed for GFPMR in aldosterone treated cells over 1 h following photobleaching (Fig 6D) .
To determine whether these results reflected the static localization of MR within the nucleus we performed fluorescence loss in photobleaching (FLIP) experiments in which the mobility of MR within the nucleus and cytoplasm was measured. First, GFP MR was observed to be highly mobile within the nucleus as photobleaching of the GFPMR signal in one corner of the nucleus of aldosterone-treated cells at 30 second intervals led to the near complete depletion of the GFPMR signal from the nucleus within 10 min (Fig 7A) . Similar rapid mobility was also observed for naïve GFPMR in both the nucleus and cytoplasm, with ablation of fluorescence within a box covering equal sections of nucleus and cytoplasm, also resulting in the loss of GFPMR fluorescence over 10 min (Fig 7B) .
FRAP of the cytoplasm of cells containing naive GFPMRs distributed equally between
nucleus and cytoplasm, demonstrated that naïve nuclear GFP MR also is not exported from the nucleus over 2h following photobleaching (Fig 7C) . Similarly, treatment of naïve cells with the export inhibitor leptomycin B had no effect on the subcellular localization of MR (data not shown). In striking contrast however, nuclear GFPMR fluorescence was recovered over a 2h period following photobleaching of the naïve GFPMR signal from the nucleus (Fig 7D) . Unexpectedly, we have observed that MRs differ from other nuclear receptors in moving continuously towards the nucleus without apparent means to return to the cytoplasm.
Nuclear import is mediated through the binding of NLSs to one of at least 20 importin nuclear transport receptors (53) . Movement of MR into the nucleus was determined to be mediated through three nuclear import signals. Each signal was uniquely regulated, with one signal being ligand-independent (NL0), one being agonist-specific (NL2) and the third responsive to both steroid agonists and antagonists (NL1). The signals were also biochemically distinct: NL1 being comprised of a bipartite basic motif; NL2 lacking an obvious basic motif and being dependent on LBD conformation; and NL0 requiring a serine/theronine motif that represents a new class of NLS. Determining whether these three NLSs mediate nuclear import through the same pathways, or whether they reflect the use of distinct nuclear transport receptors as might be predicted by their biochemistry, will be key to understanding the potential to differentially maniupulate the three NLS activities. 
27
A number of instances of transcription factors gaining access to the nucleus through cotransport have been reported. Both p160 coactivators and p300/CBP have potent NLSs and interact strongly with steroid receptors in an agonist-specific manner. However, neither appears to be important for NL2-mediated nuclear import of MR since a mutation abrogating MR interaction with these factors failed to affect NL2 activity. While it is still possible that NL2 reflects cotransport of MR through coactivating factors that interact differently with the LBD, our results provides direct evidence that NL2 function is inherent to the LBD. This also is consistent with a recent report suggesting that the GR NL2 has a specific ability to interact with importin 7 (54).
While nuclear hormone receptors are known to be exported from the nucleus, their rate of export appears to be generally much slower than is usually observed for active nuclear export pathways. Our recent results have indicated that the nuclear export of GR, and likely other nuclear receptors, may be opposed by an active nuclear retention activity that overlaps with the receptors NL1 motif 2 . Our results here with MR were even more striking, with essentially no movement of the receptor to the cytoplasm being detected within 24 h of steroid withdrawal. coactivators and p300/CBP before and after a 6 h treatment with aldosterone. 
